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ABSTRACT
Introduction: The variability of symptoms and signs caused by central nervous system (CNS) lesions make multiple sclerosis 
difficult to recognize,Introduction: This study adds the evaluation of the independent etiologic factors that may play a role in the devel-
opment of SNHL in a NICU population. We compared neonatal intensive care unit NICU infants with sensorineural hearing loss SNHL 
to age and gender matched normal hearing NICU controls.
Materials and methods: 284 consecutive NICU infants positive to the presence of risk indicators associated with permanent 
congenital, delayed-onset, or progressive hearing loss underwent to global audiological assessment. The following risk factors were 
researched, making a distinction between prenatal and perinatal risk factors: in the first group, family history of permanent childhood 
hearing impairment, consanguinity, pregnant maternal infection and drugs exposition during pregnancy; in the second group, prema-
ture birth, respiratory distress , hyperbilirubinemia requiring exchange tranfusion, very low birth weight, cranio-facial abnormality, 
perinatal infections, ototoxic drugs administration, acidosis, hyponatremia, head trauma.
Results: The analysis of the auditory deficit for infants according to numbers of risk factors showed mean values of: 78 + 28.08 
dB nHL for infants positive to two risk factors; 75.71 + 30.30 dB nHL in cases positive to three risk factors; 96.66 + 34.46 dB nHL for 
four risk factors and 85 + 35 dB nHL in case of >5 risk factors.
Conclusion: NICU infants have greater chances of developing SNHL, because of the presence of multiple risk factors; in fact, 
as the number of coexisting risk factors increases, the prevalence rate of SNHL also increases (r=0.81).
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Introduction
Infants admitted to the neonatal intensive care 
unit (NICU), who represent the 4-8% of all births, 
have an increased risk of developing congenital 
sensorineural hearing loss (2 to 4 cases per 100 
newborn infants)(1, 2); multiple risk factors have 
been associated with sensorineural hearing loss 
(SNHL). Comparing SNHL incidence with that 
of other congenital pathologies routinely screened 
at birth like phenylketonuria (1:15000 newborns) 
and hypothyroidism (1:4500 newborns), 
permanent hearing loss appears more frequent 
especially among NICU population. Unlike 
children with normal hearing, those with hearing 
loss present more difficulty developing verbal 
skills (learning vocabulary, grammar, word order 
and idiomatic expressions), language, learning 
and speech. Hearing impairment influences also 
cognitive and affective development of infants 
making consequences in their interpersonal 
relationships(3-7).
The 2007 Position Statement from the Joint 
Committee on Infant Hearing (JCIH) confirmed 
that neonates who are in NICU for >5 days, or 
who have risk factors and a shorter stay, undergo 
hearing evaluation with Transient evoked 
otoacoustic emissions (TEOAEs) and (automated) 
auditory brainstem response (ABR) testing, that 
is recommended for screening because of the 
increased occurrence of SNHL and neural (auditory 
neuropathy/dyssynchrony) loss that are known to 
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cause long-term problems on language and speech 
development in this population(8).
Some authors have studied the presence of 
risk factors identified by the Joint Committee on 
Infants Hearing (JCIH) among NICU infants(1, 
2, 9-14) but their studies concerned a relative small 
number of NICU infants, or did not have a control 
group of normal hearing infants. Risk factors that 
are commonly found among NICU infants are 
prolonged mechanical ventilation, asphyxia, low 
birth weight and ototoxic medication.
Because most of these risk factors are related 
to NICU admittance it is unclear which risk factors 
play an independent contributing role to SNHL. 
Only by comparison within the NICU population 
the risk factors specific to SNHL can be assessed. 
The Department of Audiology of Palermo 
University represents the main speech and hearing 
third level centre in Western Sicily; it daily performs 
an audiological assessment to those infants at risk 
born in Western Sicily and transferred from NICUs 
to our specialized area(15-17). Therefore this study 
adds the evaluation of the independent etiologic 
factors that may play a role in the development of 
SNHL in a NICU population(18-22). We compared 
NICU infants with SNHL to age and gender 
matched normal hearing NICU controls.
Materials and methods
284 consecutive NICU infants positive 
to the presence of risk indicators associated 
with permanent congenital, delayed-onset, or 
progressive hearing loss underwent to global 
audiological assessment. After ethical Committee 
approval, the study protocol was fully explained 
to patients or their guardians, and written informed 
consent was obtained from each patient. The 
following risk factors were researched, making 
a distinction between prenatal and perinatal risk 
factors (JCIH): in the first group, family history 
of permanent childhood hearing impairment, 
consanguinity, pregnant maternal infection 
(TORCH) and drugs exposition during pregnancy; 
in the second group, premature birth (gestational 
age ≤36 weeks), respiratory distress (IRDS), 
hyperbilirubinemia requiring exchange tranfusion, 
very low birth weight (<1500 g, VLBW), 
cranio-facial abnormality (CFA) and syndromes 
associated to HI, perinatal infections like sepsis 
and meningitis, ototoxic drugs administration 
(furosemide, dexamethason, vancomycin, 
gentamycin and tobramycin), acidosis, 
hyponatremia, head trauma(8).
An experienced audiologist and 
otorhinolaryngologist examined the condition 
of the external auditory canal and tympanic 
membrane with otoscopy, and nose, throat, head 
and face in search of ear anomalies and syndromic 
features related to hearing impairment(23-29).
The audiological assessment was performed by 
the same qualified bio-medical staff and consisted 
of ABR, TEOAE and tympanometry measurement. 
ABR measurements were recorded in a soundproof 
room; all children were in natural sleep or in 
calm conditions throughout the assessment. Both 
ears were sequentially tested. AMPLAID mk22 
auditory evoked potentials system was used for 
testing the infants. After adequate preparation of 
skin, recording silver electrodes were attached to 
upper forehead (recording electrode), the ipsilateral 
mastoid process (reference electrode) and 
contralateral mastoid process (ground electrode). 
Thus the Fpz-M1-M2 electrode montage was 
used for recording the ABR. The acoustic stimuli 
consisted of unfiltered full square wave pulses of 
100 microseconds duration and with alternating 
polarity. The clicks were delivered monaurally 
by a hand-held TDH-49 headphone, at a rate of 
21/sec. The analysis time was 15 milliseconds. 
The recording bandwidth for click threshold 
determination was 100-2500 Hz. The electrode 
and inter electrode impedance were ensured to 
be below 5 kHz and 2 kHz respectively. Each run 
consisted of summing the responses to 2000 clicks. 
Click stimuli were presented starting at a level of 
90 dB nHL. With step sizes of 10 dB the level 
was decreased until no response was found. The 
response threshold was estimated by the lowest 
level at which a response was found.
An infant was considered to have passed 
the ABR test if a replicable wave V response 
(response present on at least two identical sound 
stimulation levels) was present at 30 dB nHL in 
both the ears while sensorineural hearing loss was 
defined as elevated ABR response thresholds (>40 
dB) in one or both ears. Moreover, the absolute 
latencies and interpeak intervals as well as the 
response thresholds were recorded. Experienced 
clinical specialists interpreted the ABR response 
waves. The response latencies in milliseconds 
were obtained by establishing the peak of the 
wave and reading out the digitally displayed time. 
From the latency intensity curves the level of 
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conductive hearing loss was estimated. TEOAE 
and tympanometry measurement were used to 
confirm the diagnosis of conductive hearing loss 
when available. In particular, the first one was 
performed using the Otodynamics ILO 288 USB 
II system with the standard settings; the stimulus 
level was set to 84 dB SPL, a number of 260 
averages was used. Tympanometry was performed 
through Amplaid 766, with a probe frequency of 
220 Hz and an air pressure range of -400 to -100 
mmH2O with automatic recording.
The parents of an infant with suspicion of 
hearing impairment were informed of the results 
of the initial test and received recommendations 
to return for a follow up evaluation after 3 weeks. 
Statistical analysis was conducted with Matlab® 
computer programme; χ2 test, odds ratio (or) and/
or exact test of Fisher test were used, following 
usual conditions of application. Significance was 
set at 0.05.
Results
Of 284 NICU infants examined 168 were 
males (59.15%) and 116 females (40.85%) with a 
male:female ratio = 1.45; the age of infants at first 
diagnostic ABR measurement, ranged from 4 to 20 
weeks of life, with no statistical difference among 
the sex (t = 0.74; f.d. = 140; p = 0.26). 
Audiologic evaluation revealed the presence 
of hearing loss in 34 children (16 male and 18 
female) corresponding to 11.97% of the study 
group (Table 1).
There is no statistically significant difference 
in prevalence of SNHL among sex (χ2 = 1.17, P 
= 0.25, or = 1.74). Out of 34 SNHL infants, 30 
subjects (88.23%) were diagnosed with bilateral 
SNHL; a symmetric HL, defined by an inter-aural 
threshold difference < 30 dB, was evidenced in the 
93.33% corresponding to 28 cases (82.35% of the 
total infants suffering from SNHL), while in the 
5.88 % corresponding to 2 cases this sensorineural 
hearing loss was asymmetric (inter-aural threshold 
difference > 30 dB). 
Finally, 4 infants (11.76%) were affected by 
unilateral SNHL, with a response threshold in the 
best hearing ear < 40 dB. Among the total ears 
suffering from SNHL, our study evidenced an 
hearing threshold mean value of 82.5 ± 30.37 dB 
HL (median 75 dB HL) for the left ears, of 81.25 
± 33.04 dB HL (median 70dB HL) for the right 
ears, of 81.87± 32.05 dB HL (median 70 dB HL) 
for both ears without any difference between left 
and right ears (t=0.18, f.d.=30, P=0.85). The ABR 
response thresholds were used also to determine 
the degree of SNHL; a moderate, defined as hearing 
threshold inferior to 70 dB nHL, hearing loss was 
identified in 52.94% of SNHL corresponding to 18 
infants, severe hearing loss in 11.76% (4 cases) 
and profound hearing loss in 35.29% of cases (12 
cases).
44 NICU infants (15.49%) resulted positive 
for a specific risk factor while 142 subjects (50%) 
were positive for 2 risk factors, 48 cases (16.90%) 
presented 3 risk factors, 34 (11.97%) infants 
demonstrated 4 risk factors while only in 16 case 
>5 risk factors were found. 
Prevalence of prenatal risk factors was 
lower than that of perinatal risk factors (Table 
1) even if TORCH infection resulted an 
independent risk factor for SNHL (or=2.90).
In the second group, that includes risk 
factors occurred from birth to the 28th day 
of life, respiratory distress and prematurity 
showed the highest prevalence, with 140 
infants suffered from IRDS (49.29%) 
and 88 born preterm (30.98%). Lower 
percentage concerned other risk factors like 
hyperbilirubinemia requiring phototherapy, 
found in 50 newborns (17.60%), VLBW, that 
regarded 56 infants (19.71%), syndromes 
associated with HI and cranio -facial 
anomalies (CFA) which affected 22 children 
(7.74%)(Figure 1).
RISK FACTOR CohortN°
NHL
N°(%)*
SNHL
N°(%)*
Odds 
ratio or P-value
95% 
CI
Family history of HI 6 4(66.6) 2(33.3) 3.88 0.10 0.68-22.01
TORCH 15 11 (73.3) 4(26.6) 2.90 0.071 0.87-
9.67
Drugs administration in pregnant 18 16 (88.8) 2(11.1) 0.91 0.90 0.20-
4.16
Prematurity 88 72(81.8) 16(18.2) 2.20 0.030 1.06-4.55
IRDS 140 120(85.7) 20(16.6) 1.79 0.11 0.87-
3.68
Hyperbilirubinemia 50 38(76) 12(24) 3.04 0.0039 1.39-
6.66
VLBW 56 48(85.7) 8(14.3) 1.29 0.55 0.55-3.04
Perinatal infections 36 34(94.4) 2(5.5) 0.40 0.20 0.09-1.73
Ototoxic drugs 40 36(90) 4(10) 0.79 0.67 0.26-2.38
CFA and Syndromes associated to HI 22 22(100) 0(0) - - -
*Percentage rate relative to total cohort
Table 1: Analisys of risk factors for SNHL among NICU newborns: 
logistic regression analisys, correlation coefficient b, P-value, odds 
ratio and 95% confidence limits.
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The univariant analysis showed a statistically 
significant correlation between prematurity, 
hyperbilirubinemia and SNHL (P=0.03 with 
or=2.20 and P=0.0039 with or=3.04) with a SNHL 
prevalence respectively of 47.05% and 35.29% for 
infants with this risk factor (Table 1).
The study of the risk factors of the SNHL 
infant population demonstrated the presence of 
more risk factors in the 100%; moreover, as the 
number of coexisting risk factors increased, the 
percentage value of SNHL in infants also increases. 
In fact, among the 142 infants presenting two risk 
factors 16 were diagnosed with SNHL (11.26%), 
of the 48 infants with three risk factors 8 were 
deafness (16.6%); 6 infants (21.42%) among the 
28 with four risk factors resulted deaf and 4 infants 
of the 12 (33.33%) positive to >5 risk factors was 
hearing impaired (r = 0.81).
The analysis of the auditory deficit for infants 
according to numbers of risk factors showed mean 
values of: 78 + 28.08 dB nHL for infants positive 
to two risk factors; 75.71 + 30.30 dB nHL in cases 
positive to three risk factors; 96.66 + 34.46 dB 
nHL for four risk factors and 85 + 35 dB nHL in 
case of >5 risk factors.
Discussion
In the general population, a newborn every 
500-1000 births presents permanent hearing 
impairment (HI) greater than the incidence of 
other diseases routinely screened at birth(30-41). 
Moreover, in certain ‘higher risk’ populations, this 
incidence could increase to 8-100 cases per 1000 
infants. The importance of deafness for the public 
health comes from its tendency to cause sequelae 
and complications such as irreversible delay in 
speech and cognitive development. To prevent 
these complications, children especially who have 
certain risk factors for HI must be identified within 
three months of birth, with formal diagnosis and 
initiation of early intervention beginning before 
the 6th month of age. The goal of this report 
was to present the results of global audiological 
evaluation of 142 NICU infants for permanent 
congenital, delayed-onset, or progressive hearing 
loss, who were transferred to our Department, 
the main tertiary Speech and Hearing Center of 
Western Sicily, from all NICU centres of Western 
Sicily that decided to participate in the study from 
January 2010 to our days. 
With a prevalence rate of 11.97% of SNHL, 
our percentage is higher than those reported by 
Coenraad (1.39%), Hille (3.1%) and Robertson 
(3.2%) and inferior to those evidenced by Davis and 
Parving (32.8%), Shiu et al. (30.9%) and Pitt (32%) 
(2, 9; 41-45). According to Dauman et al., the high 
variability in incidence of SNHL among newborns 
admitted to NICU reflects an heterogeneous 
distribution of different neonatal risk factors more 
or less involved in the development of SNHL(46-53).
In addition, another consideration should be 
made for NICU babies: these newborns, in fact, 
present often multiple risk factors, a condition that 
increases the probability of hearing impairment. 
Table 1 reports logistic regression analysis for 
each risk factors in our NICU cohort; results of 
a simultaneous multiple regression analysis of the 
variation in SNHL prevalence among NICU infants 
evidenced that the relative risk for SNHL increases 
by 21.24% in preterm infants and by 19.33% in 
newborns who suffered from hyperbilirubinemia 
when respiratory distress is concomitant with these 
risk factors respectively (Figure 2). Furthermore, 
in this cohort, we observed an higher risk of SNHL 
(99.66%) in case of coexistence of prematurity and 
hyperbilirubinemia. 
Our study also underlined the role of 
gestational age and birth weight as risk factors for 
SNHL; specifically, among the 72 preterm infants, 
58 (80.55%) presented extreme prematurity and of 
them 14 (corresponding to 24.13% subjects) were 
hearing impaired (χ2=10.23; P=0.001). Among 
newborns with very low birth weight, it was 
evidenced a statistically difference between infants 
with weight < 1000g and those who weighed 
at birth≥1000g; in fact the SNHL prevalence 
Figure 1: Figure 1: Incidence of risk factors in SNHL in-
fants respect to NHL cohort.
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percentages inside the groups resulted of 14.28%, 
5.26% and 33.33% for the total infants with 
VLBW, for newborns weighed between 1000g and 
1500 g and for children with extremely low birth 
weight (<1000g) respectively (χ2=3.93; P=0.04). 
These findings are explainable considering that the 
greater the severity of prematurity and the lower 
the birth weight, more probable is the coexistence 
of condition like severe birth asphyxia or assisted 
ventilation for ≥5 days that increase the risk of 
SNHL(54-65).
Conclusion
With an incidence of 11.97% of SNHL in 
infants at risk this study demonstrates the necessity 
to implement a Newborn Hearing Screening 
program in Western Sicily; with a mean hearing 
threshold of 82.5 ± 30.37 dB HL (median 75 dB 
HL), out of speech spectrum, it underlines the 
necessity of an early diagnosis before the 6th 
month of life to prevent sequelae and complications 
such as irreversible delay in speech and cognitive 
development. NICU infants have greater chances 
of developing SNHL, because of the presence of 
multiple risk factors; in fact, as the number of 
coexisting risk factors increases, the prevalence 
rate of SNHL also increases (r=0.81), particularly 
among extreme premature and infants with weight 
< 1000g (P=0.04).
References
1) Vohr BR, Widen JE, Cone-Wesson B, Sininger YS, 
Gorga MP, Folsom RC, et al. Identification of neonatal 
hearing impairment: characteristics of infants in the 
neonatal intensive care unit and well-baby nursery. 
Ear Hear. 2000; 21(5): 373-82. 
2) Hille ET, van Straaten HI, Verkerk PH, Dutch 
NNHSWG. Prevalence and independent risk factors 
for hearing loss in NICU infants. Acta Paediatr. 2007; 
96(8): 1155-8. http://dx.doi.org/10.1111/j.1651-
2227.2007.00398.x
3) Rizzo S, Bentivegna D, Dispenza F, Mucia M, Plescia 
F, Salvago P, Sireci F, Martines  F. Audiological risk 
factors and screening strategies in NICU infants In 
Martines F. Neonatal Intensive Care Units. Nova 
Science Publishers; 2017. 1-15.
4) Yoshinaga-Itano C, Coulter D, Thomson V. The 
Colorado Newborn Hearing Screening Project: effects 
on speech and language development for children with 
hearing loss. J Perinatol. 2000; 20(8 Pt 2): S132-7. 
5) Plescia F, Lavanco G, Brancato A, Cannizzaro C, 
Dispenza F, Mucia, M, Passalacqua MI, Salvago 
P, Sireci F,Rizzo S, Cavallaro A. Pharmacological 
Therapy of Newborn Babies Admitted to the Neonatal 
Intensive Care Unit. In: Francesco Martines eds. 
Neonatal Intensive Care Units (NICUs): Clinical and 
Patient Perspectives, Levels of Care and Emerging 
Challenges. Chapter 6; Nova publisher; 2017. 1-15
6) Fortnum H, Davis, A, Butler, A, Stevens, J. Health 
service implications of changes in aetiology and 
referral patterns of hearing impaired children in Trent 
1985-1993, Report to Trent Regional Health Authority. 
UK: Nottingham, MRC Institute of Hearing Research, 
1996.
7) Martines F, Martines E, Ballacchino A, Salvago 
P. Speech perception outcomes after cochlear 
implantation in prelingually deaf infants: The Western 
Sicily experience. Int J Pediatr Otorhinolaryngol. 
2013; 77(5): 707-13. http://dx.doi.org/10.1016/j.
ijporl.2013.01.023
8) American Academy of Pediatrics JCoIH. Year 2007 
position statement: Principles and guidelines for 
early hearing detection and intervention programs. 
Pediatrics. 2007; 120(4): 898-921. http://dx.doi.
org/10.1542/peds.2007-2333 
9) Sireci F, Ferrara S, Gargano R, Mucia M, Plescia 
F, Rizzo S, Salvago P, Martines F. Hearing loss in 
Neonatal Intensive Care Units (NICUs): follow-up 
surveillance In Martines F. Neonatal Intensive Care 
Units. Nova Science Publishers; 2017. 1-15.
10) Robertson CM, Howarth TM, Bork DL, Dinu IA. 
Permanent bilateral sensory and neural hearing loss 
of children after neonatal intensive care because of 
extreme prematurity: a thirty-year study. Pediatrics. 
2009; 123(5): e797-807. http://dx.doi.org/10.1542/
peds.2008-2531
11. Declau F, Boudewyns A, Van den Ende J, Peeters A, van 
den Heyning P. Etiologic and audiologic evaluations 
after universal neonatal hearing screening: analysis of 
170 referred neonates. Pediatrics. 2008;121(6):1119-
26. http://dx.doi.org/10.1542/peds.2007-1479
12) Nield TA, Schrier S, Ramos AD, Platzker AC, 
Warburton D. Unexpected hearing loss in high-risk 
infants. Pediatrics. 1986; 78(3): 417-22. 
13) Salamy A, Eldredge L, Tooley WH. Neonatal status 
and hearing loss in high-risk infants. J Pediatr. 1989; 
114(5): 847-52. 
14) Borradori C, Fawer CL, Buclin T, Calame A. Risk 
factors of sensorineural hearing loss in preterm 
infants. Biol Neonate. 1997; 71(1): 1-10. 
Figure 2: Global odds ratio (G.or) and 95% confidence in-
tervals (CI) for joint effect of determinants among NICU 
population (P<0.001).
1006                    Francesco Gazia, Pietro Abita et Al
15) Borg E. Perinatal asphyxia, hypoxia, ischemia and 
hearing loss. An overview. Scand Audiol. 1997; 26(2): 
77-91. 
16) Martines F, Martines E, Mucia M, Sciacca V, 
Salvago P. Prelingual sensorineural hearing loss and 
infants at risk: Western Sicily report. Int J Pediatr 
Otorhinolaryngol. 2013;77(4):513-8. http://dx.doi.
org/10.1016/j.ijporl.2012.12.023
17) Salvago P, Martines E, Martines F. Prevalence and risk 
factors for sensorineural hearing loss: Western Sicily 
overview. Eur Arch Otorhinolaryngol. 2013; 270(12): 
3049-56. http://dx.doi.org/10.1007/s00405-013-2379-2
18) Galletti B, Freni F, Cammaroto G, Catalano N, 
Gangemi G, Galletti F. Vocal outcome after CO2 laser 
cordectomy performed on patients affected by early 
glottic carcinoma. J Voice. 2012 Nov; 26(6): 801-5.
19) Marseglia L, D’Angelo G, Impellizzeri P, Salvo V, 
Catalano N, Bruno R, Galletti C, Galletti B, Galletti 
F, Gitto E. Neonatal stridor and laryngeal cyst: Which 
comes first? Pediatr Int. 2017 Jan; 59(1): 115-117.
20) Canevari FR, Martines F, Sorrentino R, Nicolotti M, 
Sireci F. Pseudoaneurysm of superior thyroid artery 
following a transesophageal echocardiography: a case 
presentation. Euromediterranean Biomedical Journal 
2017, 12(03): 010-012
21) Galletti B, Gazia F, Freni F, Sireci F, Galletti F. 
Endoscopic sinus surgery with and without computer 
assisted navigation: A retrospective study. Auris Nasus 
Larynx. 2018; 10.1016/j.anl.2018.11.004
22) Galletti B, Bruno R, Catalano N, Cammaroto G, Freni 
F. Follicular carcinoma on a radio-treated ectopic 
lingual thyroid. Chirurgia (Turin). 2016 June; 29(3): 
88-91
23) Santoro R, Mannella VK, Freni F, Galletti F. 
Penetrating foreign body in the nasal floor through 
nasolacrimal duct. BMJ Case Rep. 2014 Jun 12; 2014
24) Sireci F, Nicolotti M, Battaglia P, Sorrentino R, 
Castelnuovo P, Canevari FR.  Canine fossa puncture in 
endoscopic sinus surgery: report of two cases. Braz J 
Otorhinolaryngol. 2017 Sep - Oct;83(5):594-599. doi: 
10.1016/j.bjorl.2017.03.001.
25) Martines F, Salvago P, Ferrara S, Messina G, Mucia 
M, Plescia F, Sireci F. Factors influencing the 
development of otitis media among Sicilian children 
affected by upper respiratory tract infections. 
Braz J Otorhinolaryngol. 2015 Jul 21. pii: S1808-
8694(15)00091-9.
26) Galletti B, Santoro R, Mannella VK, Caminiti F, 
Bonanno L, De Salvo S, Cammaroto G, Galletti F. 
Olfactory event-related potentials: a new approach 
for the evaluation of olfaction in nasopharyngeal 
carcinoma patients treated with chemo-radiotherapy. 
J Laryngol Otol. 2016 May; 130(5): 453-61.
27) Ottaviano G, Maculan P, Borghetto G, Favero V, 
Galletti B, Savietto E, Scarpa B, Martini A, Stellini 
E, De Filippis C, Favero L. Nasal function before 
and after rapid maxillary expansion in children: 
A randomized, prospective, controlled study. Int J 
Pediatr Otorhinolaryngol. 2018 Dec; 115: 133-138.
28) Galletti C, Cammaroto G, Galletti F, Camps-Font 
O, Gay-Escoda C, Bara-Casaus JJ. Dental implants 
after the use of bichat’s buccal fat pad for the sealing 
of oro-antral communications. A case report and 
literature review. J Clin Exp Dent.  2016 Dec 1; 8(5): 
e645-e649.
29) Cammaroto G, Montevecchi F, D’Agostino G, 
Zeccardo E, Bellini C, Galletti B, Shams M, Negm 
H, Vicini C. Tongue reduction for OSAHS: TORSs 
vs coblations, technologies vs techniques, apples 
vs oranges. Eur Arch Otorhinolaryngol. 2017 Feb; 
274(2): 637-645. doi: 10.1007/s00405-016-4112-4.
30) Freni F, Galletti B, Galletti F, Dionigi G. Improved 
outcomes for papillary thyroid microcarcinoma 
care: active surveillance and case volume. Ther Adv 
Endocrinol Metab. 2018 Jul; 9(7): 185-186.
31) Sun H, Zanghì GN, Freni F, Dionigi G. Continuous 
and intermitted nerve monitoring in thyroid surgery: 
two complementary devices. Gland Surg. 2018 Aug; 
7(Suppl 1): S80-S81
32) Cristofari E, Cuda D, Martini A, Forli F, Zanetti D, Di 
Lisi D, Marsella P, Marchioni D, Vincenti V, Aimoni 
C, Paludetti G, Barezzani MG, Leone CA, Quaranta 
N, Bianchedi M, Presutti L, Della Volpe A, Redaelli de 
Zinis LO, Cantore I, Frau GN, Orzan E, Galletti F, Vitale 
S, Raso F, Negri M, Trabalzini F, Livi W, Piccioni LO, 
Ricci G, Malerba P. A Multicenter Clinical Evaluation 
of Data Logging in Cochlear Implant Recipients Using 
Automated Scene Classification Technologies. Audiol 
Neurootol. 2017; 22(4-5): 226-235.
33) Ciodaro F, Mannella VK, Cammaroto G, Bonanno 
L, Galletti F, Galletti B. Oral gabapentin and 
intradermal injection of lidocaine: is there any role in 
the treatment of moderate/severe tinnitus? Eur Arch 
Otorhinolaryngol. 2015 Oct; 272(10): 2825-30.
34) Galletti B, Mannella VK, Santoro R, Rodriguez-
Morales AJ, Freni F, Galletti C, Galletti F, Cascio A. 
Ear, nose and throat (ENT) involvement in zoonotic 
diseases: a systematic review. J Infect Dev Ctries. 
2014 Jan 15;8(1):17-23. doi:  10.3855/jidc.4206.
35) Salvago P, Rizzo S, Bianco A, Martines F. Sudden 
sensorineural hearing loss: is there a relationship between 
routine haematological parameters and audiogramshapes? 
Int J Audiol. 2017 Mar;56(3):148-153.
36) Galletti F, Cammaroto G, Galletti B, Quartuccio N, Di 
Mauro F, Baldari S. Technetium-99m (99mTc)-labelled 
sulesomab in the management of malignant external 
otitis: is there any role? Eur Arch Otorhinolaryngol. 
2015 Jun;272(6): 1377-82.
37) Martines F, Ballacchino A, Sireci F, Mucia M, La 
Mattina E, Rizzo S, Salvago P. Audiologic profile 
of OSAS and simple snoring patients: the effect of 
chronic  nocturnal intermittent hypoxia on auditory 
function. Eur Arch Otorhinolaryngol. 2016 Jun; 
273(6): 1419-24.
38) Motta G, Motta S, Cassano P, Conticello S, Ferretti 
M, Galletti B, Garozzo A, Larotonda G, Mansi N, 
Mevio E, Motta G, Quaremba G, Serra A, Tarantino 
V, Tavormina P, Vicini C, Vigili MG, Testa D. Effects 
of guidelines on adeno-tonsillar surgery on the clinical 
behaviour of otorhinolaryngologists in Italy. BMC Ear 
Nose Throat Disord. 2013 Jan 7; 13: 1.
39) Meyer C, Witte J, Hildmann A, Hennecke KH, 
Schunck KU, Maul K, et al. Neonatal screening for 
hearing disorders in infants at risk: incidence, risk 
factors, and follow-up. Pediatrics. 1999;104(4 Pt 1): 
900-4. 
40) Mehl AL, Thomson V. Newborn hearing screening: 
the great omission. Pediatrics. 1998; 101(1): E4. 
NICU infants & SNHL: experience of a Western Sicily tertiary care centre                    1007
41) Ballacchino A, Mucia M, Cocuzza S, Ferrara S, 
Martines E, Salvago P, et al. Newborn Hearing 
Screening in Sicily: Lesson Learned. Acta Medica 
Mediterr. 2013; 29(4): 731-4. 
42) Davis A, Parving A. Towards appropriate 
epidemiological data on childhood hearing disability: 
A comparative European study of birth cohorts 1982-
88. J Audiol Med. 1994; 3(1): 35-47. 
43) Shiu J, Purvis, M, Sutton, G. Detection of childhood 
hearing impairment in the Oxford Region. Report 
of the Regional audit project. Oxford, UK: Oxford 
University1996 Contract No.: I.
44) Pitt T. Management and outcome: children fitted with 
hearing aids in Ireland. Br J Audiol. 1995; 29(4): 199-207. 
45) Coenraad S, Goedegebure A, Hoeve LJ. An initial 
overestimation of sensorineural hearing loss in NICU 
infants after failure on neonatal hearing screening. 
Int J Pediatr Otorhinolaryngol. 2011; 75(2): 159-62. 
http://dx.doi.org/10.1016/j.ijporl.2010.10.026
46) Dauman R, Roussey M, Belot V, Denoyelle F, 
Roman S, Gavilan-Cellie I, et al. Screening to detect 
permanent childhood hearing impairment in neonates 
transferred from the newborn nursery. Int J Pediatr 
Otorhinolaryngol. 2009; 73(3): 457-65. http://dx.doi.
org/10.1016/j.ijporl.2008.12.001
47) Catalano N, Cammaroto G, Galletti B, Freni F, Nicita 
RA, Azielli C, Galletti F. The role of cVEMPs and 
vHIT in the evaluation of otosclerosis and its eventual 
vestibular impairment: preliminary findings. B-ENT. 
2017; 13(1 Suppl 27): 31-36
48) Freni F, Mannella VK, Cammaroto G, Azielli C, 
Cappuccio C, Galletti F. Classic and reversal steps 
stapedotomy performed with CO2 laser: a comparative 
analysis. Eur Arch Otorhinolaryngol. 2014 May; 
271(5): 981-6.
49) Martines F, Sireci F, Cannizzaro E, Costanzo R, 
Martines E, Mucia M, Plescia F, Salvago P. Clinical 
observations and risk factors for tinnitus in a Sicilian 
cohort. Eur Arch Otorhinolaryngol. 2015 Oct; 272(10): 
2719-29.
50) Bruno R, Aversa T, Catena M, Valenzise M, Lombardo 
F, De Luca F, Wasniewska M. Even in the era of 
congenital hypothyroidism screening mild and 
subclinical sensorineural hearing loss remains a 
relatively common complication of severe congenital 
hypothyroidism. Hear Res. 2015 Sep; 327: 43-7.
51) Amorini M, Romeo P, Bruno R, Galletti F, Di Bella C, 
Longo P, Briuglia S, Salpietro C, Rigoli L. Prevalence 
of Deafness-Associated Connexin-26 (GJB2) and 
Connexin-30 (GJB6) Pathogenic Alleles in a Large 
Patient Cohort from Eastern Sicily. Ann Hum Genet. 
2015 Sep; 79(5): 341-349.
52) Miroddi M, Bruno R, Galletti F, Calapai F, Navarra 
M, Gangemi S, Calapai G. Clinical pharmacology of 
melatonin in the treatment of tinnitus: a review. Eur J 
Clin Pharmacol. 2015 Mar; 71(3): 263-70.
53) Naro A, Leo A, Cannavò A, Buda A, Bruno R, Salviera 
C, Bramanti P, Calabrò RS. Audiomotor Integration in 
Minimally Conscious State: Proof of Concept! Neural 
Plast. 2015; 2015: 391349. doi: 10.1155/2015/391349.
54) Marlow ES, Hunt LP, Marlow N. Sensorineural 
hearing loss and prematurity. Arch Dis Child Fetal 
Neonatal Ed. 2000; 82(2): F141-4. 
55) Leslie GI, Kalaw MB, Bowen JR, Arnold JD. Risk 
factors for sensorineural hearing loss in extremely 
premature infants. J Paediatr Child Health. 1995; 
31(4): 312-6. 
56) Naro A, Leo A, Bruno R, Cannavò A, Buda A, Manuli 
A, Bramanti A, Bramanti P, Calabrò RS. Reducing the 
rate of misdiagnosis in patients with chronic disorders 
of consciousness: Is there a place for audiovisual 
stimulation? Restor Neurol Neurosci. 2017; 35(5): 
511-526.
57) Naro A, Bruno R, Leo A, Russo M, Salviera C, 
Bramanti A, Bramanti P, Calabrò RS. Twist and turn 
into chronic disorders of consciousness: Potential 
role of the auditory stapedial reflex. Restor Neurol 
Neurosci. 2017; 35(1): 77-85.
58) Leo A, Naro A, Cannavò A, Pisani LR, Bruno R, 
Salviera C, Bramanti P, Calabrò  RS. Could autonomic 
system assessment be helpful in disorders of 
consciousness diagnosis? A neurophysiological study. 
Exp Brain Res. 2016 Aug; 234(8): 2189-99
59) Ciodaro F, Mannella VK, Nicita RA, Cammaroto G, 
Bruno R, Galletti B, Freni F, Galletti F. Therapeutic 
efficacy of the Galletti-Contrino manoeuvre for 
benign paroxysmal positional vertigo of vertical 
semicircular canals in overweight subjects. Eur Arch 
Otorhinolaryngol. 2018 Oct; 275(10): 2449-2455.
60) Naro A, Leo A, Cannavò A, Buda A, Bruno R, Salviera 
C, Bramanti P, Calabrò RS. Audiomotor Integration in 
Minimally Conscious State: Proof of Concept! Neural 
Plast. 2015; 2015: 391349
61) Mento C, Galletti F, Freni F, Longo P, Testini G, Rizzo 
A, Settineri S. The role of temperament in traumatic 
hearing loss: a single case study of a cochlear-
implanted patient. Int J Adolesc Med Health. 2016 
Feb; 28(1): 107-13.
62) De Salvo S, Bonanno L, Giorgianni R, Muscarà N, 
Freni F, Caminiti F, Milardi D, Bramanti P, Marino 
S. Functional MRI and laser-evoked potentials 
evaluation in Charcot-Marie-Tooth syndrome. Neurol 
Sci. 2018 Jul; 39(7):1185-1189.
63) Puccio G, Giuffré M, Piccione M, Piro E, Malerba V, 
Corsello G. Intrauterine growth pattern and birthweight 
discordance in twin pregnancies: a retrospective study. 
Ital J Pediatr. 2014 May 5; 40:43.
64) Viaggi CD, Cavani S, Pierluigi M, Antona V, Piro 
E, Corsello G, Mogni M, Piccione M, Malacarne 
Characterization of a complex rearrangement 
involving chromosomes 1, 4 and 8 by FISH and array-
CGH.M. J Appl Genet. 2012 Aug; 53(3): 285-8
65) Galletti B, Gazia F, Freni F, Nicita RA, Bruno R, 
Galletti F. Chronic Otitis Media Associated with 
Cholesteatoma in a Case of the Say-Barber-Biesecker-
Young-Simpson Variant of Ohdo Syndrome. Am J 
Case Rep 2019; 20: 175-178
_________
Corresponding Author:
Francesco Gazia
Department of Adult and Development Age 
nolaryngology, University of Messina
Via Consolare Valeria 1, 98125, Messina (ME)
E-mail: ssgazia@gmail.co
(Italy)
